Skip to content

Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS)

Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS)

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01381354
Enrollment
38
Registered
2011-06-27
Start date
2010-10-31
Completion date
2016-05-31
Last updated
2018-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

Secondary Progressive Multiple Sclerosis, primary progressive multiple sclerosis

Brief summary

The study will use a multimodal therapeutic lifestyle intervention consisting of a study diet, stressing more vegetables and fruit, elimination of foods at greatest risk for food allergy, meditation, self massage, progressive exercise and neuromuscular electrical stimulation for rehabilitation of gait and fatigue disability in the setting of secondary and primary progressive multiple sclerosis with gait disability.

Detailed description

Restoration of function is very rare in individuals with MS who have experienced gradual worsening in the absence of acute MS symptoms (relapses) and partial or complete recovery of those acute symptoms (remissions). A recent case report of a patient with secondary progressive MS documented a transition from scooter dependence to mild gait disability following the initiation of electrotherapy in the form of neuromuscular electrical stimulation and nutritional interventions aimed increasing the nutrient density and decreasing the risk of food sensitivity and food allergies. Multiple studies of neuromuscular electrical stimulation in athletes, cerebral palsy and stroke patients have demonstrated gains in strength and coordination. Multiple authors have reported that antioxidants, essential amino acids and micronutrient rich diets are neuroprotective. It is likely that the combination of the intensive nutrition and the electrotherapy contributed to the marked gains in improvement. However in the absence of an additional case report the strength of the association remains unknown. The intent of this study is to replicate the interventions from the case report as closely as possible. Our primary objective is to measure how many and how completely subjects implement 1) the nutritional interventions, 2) the home exercise program intervention, and 3) the electrotherapy intervention and if the improve improved nutrition and exercise are associated with improved function. To assess improvements in function will measure 1) the change in nutritional status as reported in food frequency surveys, 24 hr dietary recalls, 2) change in neurocognitive testing and behaviors, 3) change in self-reported function and disability scales, 4) change in gait and 5) change in medications doses or classes for MS related symptoms. Subjects will be followed for three years. After the first year, subjects will not receive intensive support from the study team. The subjects return at months 18, 24 and 36 to assess adherence with study interventions, function and quality of life. Nutrition intake is assessed again at 24 and 36 months. To assess for safety we will assess safety labs (kidney and liver function tests) and changes in weight, and self reported side effects questionnaire.

Interventions

Progressive strengthening exercises designed to improve core muscles and muscles of ambulation.

DEVICENeuromuscular electrical stimulation delivered using the electrical therapy device EMPI 300 PV

Neuromuscular electrical stimulation to train core muscles and ambulation muscles. Device is Empi 300 manufactured by DJO Inc.

Diet based upon a Paleolithic diet and structured to increase the consumption of greens, sulfur rich vegetables, bright colors, seaweed and omega 3 fatty acid rich foods.

DIETARY_SUPPLEMENTOmega 3 fatty acids

4 grams daily by mouth.

DIETARY_SUPPLEMENTFull Spectrum vitamin

Two capsules daily.

DIETARY_SUPPLEMENTEssential - hydroxytyrosol

Two capsules twice daily.

DIETARY_SUPPLEMENTMaltodextrin fiber supplement

One scoop daily.

DIETARY_SUPPLEMENTMineral boost (magnesium)

Two capsules daily

DIETARY_SUPPLEMENTNiacinamide

500 mg daily

DIETARY_SUPPLEMENTMethyl B12

Methyl B12 1000 mcg daily

DIETARY_SUPPLEMENTTaurine

one gram daily

DIETARY_SUPPLEMENTcreatine

one teaspoon daily

DIETARY_SUPPLEMENTthiamine

100 mg daily

DIETARY_SUPPLEMENTriboflavin

200 mg daily

DIETARY_SUPPLEMENTN acetylcysteine

1 gram daily

DIETARY_SUPPLEMENTalpha lipoic acid

300 mg twice daily

DIETARY_SUPPLEMENTL acetyl carnitine

500 mg twice daily

DIETARY_SUPPLEMENTmethyl folate

1000 mcg one pill four times a week

DIETARY_SUPPLEMENTcoenzyme Q

100 mg daily

BEHAVIORALmeditation

meditation 15 minutes daily

BEHAVIORALself massage

self massage of hands, feet, ears 15 minutes daily

BEHAVIORALlearning

completing puzzles or learning 15 minutes daily

DIETARY_SUPPLEMENTCoconut oil

If excessive weight loss occurs, the subject will add 1-2 tablespoons of coconut oil daily to smoothies or foods eaten.

Sponsors

Direct MS Canada
CollaboratorUNKNOWN
DJO Incorporated
CollaboratorINDUSTRY
Pinnaclife Inc.
CollaboratorINDUSTRY
TZ Press, LLC
CollaboratorUNKNOWN
University of Iowa
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Secondary or primary progressive multiple sclerosis * Some level of gait disability * Tolerance for test electrical therapy session * Successful completion of two week Run-IN phase completing the daily logs - * Demonstrating \> 80% compliance with dietary and behavioral interventions

Exclusion criteria

* Antiplatelet or blood thinning medication * Cognitive disability or psychiatric disorder making compliance with study interventions difficult * Implanted electronic medical device * Change in medication in the prior three months * Active cancer treatment (skin basal cell or squamous cancer is not an

Design outcomes

Primary

MeasureTime frameDescription
Fatigue severity scaleBaseline, 3 M, 6M, 9M,12 MSelf reported fatigue severity scale, (agreement with 9 questions describing impact of fatigue on daily activities)

Secondary

MeasureTime frameDescription
Short Form 36baseline, 3M, 6M, 9M, 12M, 18M, 24M, 36 MSelf reported function in multiple domains.
Mood scalesBaseline, 3 M, 6M, 9M, 12MBeck depression index, Beck anxiety index
Cognitive Scalesbaseline, 3 M, 6M, 9M, 12 MCognitive stability index or cognitive stability test, subscales of Dkef, Wtar, Wais III.
Medical Symptoms Questionnairebaseline, 1 M, 2M, 3M, 4M, 5M, 6M, 7M, 8M, 9M, 10 M, 11M, 12M, 18M, 24M, 36MDetailed review of systems which is scored 0 to 4 for each item.
Side effects logBaseline, 1M, 2M, 3M, 4M, 5M, 6M, 7M, 8M, 9M, 10 M, 11M, 12MQuestions about potential side effects from vitamin, supplements and diet, questions about potential side effects from NMES, and questions about potential side effects from exercise.
MS FunctionBaseline, 3 M, 6M, 9M, 12M, 18M, 24M, 36MSelf reported disability scales (from North American Research committee on Multiple Sclerosis)
Multiple Sclerosis Spasticity Scale-88Baseline, 3M, 6M,9M and 12M, 18M, 24M, 36M88 Questions about the impact of spasticity on various activities of daily living
Daily logBaseline, 1M, 2M, 3M, 4M, 5M, 6M, 7M, 8M, 9M, 10 M, 11M, 12MDaily reports of foods consumed, exercises and activities completed.
Vitamin logBaseline, 1M, 2M, 3M, 4M, 5M, 6M, 7M, 8M, 9M, 10 M, 11M, 12MLog of vitamins supplement bottles date opened, date emptied, pill size, number of pills in bottle.
Medical examinationBaseline, 12 MMedical examination
Neurological examinationBaseline and 12 MNeurological examination
Exposure history formBaselineHistory of exposures to chemicals.
Health questionsBaselinehealth questions about chronic disease states
Menses and pregnancy riskBaseline, 3M, 6M, 9M, 12MQuestions about menses and potential for pregnancy
Medication auditBaseline, 12 MMedications
Functional diagnosesBaselineQuestions about past medical history
Manual motor testingBaseline, 3M, 6M, 9M, 12MManual motor testing of arms, legs and core muscle groups.
Berg Balancebaseline, 3M, 6M, 9M, 12MTests of balance which are progressively more challenging.
Modified Ashworthbaseline, 3M, 6M, 9M, 12MTest of spasticity by physical examination.
Circumferencebaseline, 3M, 6M, 9M, 12MCirc. of waist, hips, R and+ L calf and R. and L. thigh.
Peak flowbaseline, 3M, 6M, 9M, 12MPeak expiratory flow rate.
Number of falls in prior two monthsBaseline, 3M, 6M, 9M,12M, 18M, 24M, 36MSelf reported number of falls and associated factors contributing to fall and severity of fall related injuries.
Dietary complianceBaseline, 6 month and 12 month, 36 monthAssessments, self report, Harvard Food Frequency (baseline, 12 month), 24 hour dietary recalls (6M)
Blood pressurebaseline, 3M, 6M, 9M, 12Mblood pressure
Waist/ Hip ratiobaseline, 3M, 6M, 9M, 12Mcircumference of waist over the circumference of hip
MS quality of life- 54Baseline and months 3,6,9,12,18,24,and 36Quality of life questionnaires asking about various aspects of daily life.
Blood BiomarkersBaseline, 12 monthsBlood biomarkers of inflammation, and nutritional status.
Change in functional and structural brain Magnetic Resonance Imaging (MRI) measuresBetween 1 and 12 month post interventionFollowing sequences: T1 weighted - Pre Gadolinium T1 weighted -Post Gadolinium T2 weighted FLAIR functional MRI during cognitive task Resting state functional MRI Diffusion Tensor Imaging
Fatigue severity scale18 M, 24 M, 36 MSelf reported fatigue severity scale, (agreement with 9 questions describing impact of fatigue on daily activities)
Get up and go test timeBaseline, 3M, 6M, 9M, 12M, 18M, 24M, 36MTotal time to get up from chair, walk 10 feet and come back and sit down on the chair. Step and stride length, step and stride duration and double support time.
Change in weight and Body mass index (BMI)Baseline, 3M, 6M, 9M, 12M, 18M, 24M, 36Mweight measured in Kg Body mass index (BMI)
Blood safety biomarkersBaseline, 1M, 3M, 6M, 9M, 12M, 18M, 24M, 36MKidney and liver function tests and complete blood count
9 hole peg board testBaseline, 3M, 6M, 9M,12M, 18M, 24M, 36MTime to put 9 pegs in holes and take them out.
Paced auditory serial addition task (PASAT)Baseline, 3M, 6M,9M,12M, 18M,24M,36MAddition of two consecutive numbers during a series of numbers heard by subject.
Veteran specific activity questionnaireBaseline, 3M, 6M, 9M, 12M, 18M,24M,36MQuestions about the maximum physical activity level.
Form 38- Daily life12M, 18M, 24M, 36MQuestions about stressful life events.
25 foot walkbaseline, 3M, 6M, 9M, 12M, 18M, 24M 36MAverage walking speed calculated from 25 foot walk. Distance (feet)walked divided by time in seconds. Step and stride length, step and stride duration.
Stool microbial profileBaseline and 12MDNA probe for bacteria, parasites and yeast DNA.
Harvard food frequency questionnaire and 24 hour food recallsBaseline, 12M, 24M and 36MQuestions regarding food intake and frequency of type of food consumed in last one year. Phone interview asking about food consumed in last 24 hours.
Bio impedance analysisBaseline, 12M, 24M and 36MTest to analyze body composition.
Exercise and electrical stimulation daily logDaily baseline through 12M, 14 day-logs before/after 18M, 24M and 36MRecord of exercise, use of electrical stimulation on muscles and physical activity.
Urine toxicologyBaseline and 12 M24 hours urine collection and measurement of heavy metals.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026